Tissue functions mediated by β 3-adrenoceptors - Findings and challenges

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 2, 2010, Pages 103-108

  Michel, Martin C ^a   Ochodnicky, Peter ^a   Summers, Roger J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MONASH UNIVERSITY   (Australia)

Author keywords

3 Adrenoceptor; BRL 37 344; CL 316 243; L 748 337; SR59230A; Vasodilatation

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; L 748337; UNCLASSIFIED DRUG;

ADIPOCYTE; BLADDER; BROWN ADIPOSE TISSUE; DESENSITIZATION; DRUG EFFICACY; HUMAN; LIPOLYSIS; MUSCLE RELAXATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; THERMOGENESIS; VASODILATATION; WHITE ADIPOSE TISSUE;

ADRENERGIC BETA-3 RECEPTOR AGONISTS; ANIMALS; DRUG DESIGN; HUMANS; ORGAN SPECIFICITY; RECEPTORS, ADRENERGIC, BETA-3;

EID: 77955553853     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0529-2     Document Type: Review

References (71)

1. 2 on the primary bladder afferent activity of the rat. Neurourol Urodyn in press
2. 3-adrenoceptor agonists on pharmacology, physiology and obesity drug discovery Naunyn-Schmiedeberg's Arch Pharmacol 378 225 240 10.1007/s00210-008-0271-1 1:CAS:528: DC%2BD1cXosVCrsLY%3D
3. JR Arch AT Ainsworth MA Cawthorne V Piercy MV Sennitt VE Thody C Wilson S Wilson 1984 Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs Nature 309 163 165 10.1038/309163a0 1:CAS:528: DyaL2cXktFOitrw%3D 6325935
4. P Arner E Kriegholm P Engfeldt 1991 In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue J Pharmacol Exp Ther 259 317 323 1:CAS:528:DyaK3MXmslWhtbY%3D 1681086
5. 3-adrenoceptor agonist induces pancreatic islet blood flow and insulin secretion in rats Eur J Pharmacol 298 287 292 10.1016/0014-2999(95) 00802-0 1:CAS:528:DyaK28Xhsleiu7s%3D 8846828
6. 3-adrenoceptor in human near-term myometrium Br J Pharmacol 130 1960 1966 10.1038/sj.bjp.0703491 1:CAS:528:DC%2BD3cXmtFems7w%3D 10952688
7. M Bardou C Rouget M Breuiller-Fouche C Loustalot E Naline P Sagot R Frydman EJ Morcillo C Advenier M-J Leroy JJ Morrison 2007 Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs? BMC Pregnancy and Childbirth 7 Suppl 1 S14 10.1186/1471-2393-7-S1-S14 17570158
8. 3-adrenoceptor mRNA in human tissues Eur J Pharmacol 289 223 228 10.1016/0922-4106(95)90098-5 1:CAS:528:DyaK2MXlt1Wjsbo%3D 7621895
9. JD Bloom MD Dutia BD Johnson A Wissner MG Burns EE Largis JA Dolan TH Claus 1992 Disodium (R, R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1, 3-benzodioxole-2, 2-dicarboxylate (CL 316, 243). A potent β-adrenergic agonist virtually specific for β3 receptors. A promising antidiabetic and antiobesity agent J Med Chem 35 3081 3084 10.1021/jm00094a025 1:CAS:528:DyaK38XltlWisrw%3D 1354264
10. RA Bond DE Clarke 1988 Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α- and β-subtypes Br J Pharmacol 95 723 734 1:CAS:528:DyaL1cXmt1eiuro%3D 2905184
11. O-E Brodde 2007 β-Adrenoceptor blocker treatment and the cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure Naunyn-Schmiedeberg's Arch Pharmacol 374 361 372 10.1007/s00210-006- 0125-7 1:CAS:528:DC%2BD2sXhsVersrg%3D
12. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle Int J Obes Relat Metab Disord 23 1057 1065 10.1038/sj.ijo.0801039 1:CAS:528:DyaK1MXnt1Ckurk%3D 10557026
13. 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder Eur Urol Suppl 7 239
14. 3-adrenergic receptor J Pharmacol Exp Ther 271 1253 1258 1:CAS:528:DyaK2MXislelt70%3D 7996434
15. Ca-L in human atrial myocardium at 37°C Naunyn-Schmiedeberg's Arch Pharmacol 381 Suppl. 1 15
16. 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function Proc Natl Acad Sci USA 100 5531 5536 10.1073/pnas.0931347100 1:CAS:528:DC%2BD3sXjs1yiurc%3D 12707413
17. 3 receptor? J Pharmacol Exp Ther 272 446 451 1:CAS:528:DyaK2MXjtFSqtbk%3D 7815362
18. 3-adrenoceptor agonist SRsA inhibits gastric acid secretion in the conscious rat Naunyn-Schmiedeberg's Arch Pharmacol 356 263 265 10.1007/PL00005050 1:CAS:528:DyaK2sXkslGmsLk%3D
19. 3-adrenoceptors Br J Pharmacol 116 1945 1947 8640330
20. 3-adrenoceptor mRNA in rat tissues Br J Pharmacol 117 210 216 1:CAS:528:DyaK28Xlt1Cksg%3D%3D 8825365
21. BA Evans M Sato M Sarwar DS Hutchinson RJ Summers 2010 Ligand-directed signalling at β-adrenoceptors Br J Pharmacol 159 1022 1038 10.1111/j.1476-5381.2009.00602.x 1:CAS:528:DC%2BC3cXjs1ektrk%3D 20132209
22. DS Fletcher MR Candelore D Grujic BB Lowell S Luell VS Susulic DE Macintyr 1998 Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor J Pharmacol Exp Ther 287 720 724 1:CAS:528: DyaK1cXnsVertbk%3D 9808702
23. 2- adrenergic agonists Is mediated through receptor G protein uncoupling J Clin Endocrinol Metab 90 2882 2887 10.1210/jc.2004-1732 1:CAS:528: DC%2BD2MXkt1WgtL8%3D 15728216
24. 3-adrenoceptor in human and rat detrusor muscle J Urol 161 680 685 10.1016/S0022-5347(01)61994-3 1:CAS:528:DyaK1MXms1GrtQ%3D%3D 9915482
25. 3-adrenoceptor in the human heart J Clin Invest 98 556 562 10.1172/JCI118823 1:CAS:528:DyaK28XksFClt7g%3D 8755668
26. 3-adrenoceptor agonist Neurobiol Aging 31 614 624 10.1016/j.neurobiolaging.2008.05.018 1:CAS:528:DC%2BC3cXhvFGgtr8%3D 18632189
27. 3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health Am J Physiol 294 G1114 G1119 1:CAS:528:DC%2BD1cXlvFCisrc%3D
28. S Guimaraes D Moura 2001 Vascular adrenoceptors: an update Pharmacol Rev 53 319 356 1:CAS:528:DC%2BD3MXkt1Gnu74%3D 11356987
29. N Hamdani J van der Velden 2009 Lack of specificity of antibodies directed against human beta-adrenergic receptors Naunyn-Schmiedeberg's Arch Pharmacol 379 403 407 10.1007/s00210-009-0392-1 1:CAS:528:DC%2BD1MXitFKitrw%3D
30. A Hoey C Jackson G Pegg M Sillence 1996 Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol Br J Pharmacol 117 712 716 1:CAS:528:DyaK28XhsVersLo%3D 8646418
31. Horinouchi T, Koike K (2001) Agonist activity of SR59230A at atypical β-adrenoceptors in guinea pig gastric fundus and duodenum. Eur J Pharmacol 416:165-168
32. 3-adrenoceptor Naunyn-Schmiedeberg's Arch Pharmacol 373 158 168 10.1007/s00210-006-0056-3 1:CAS:528:DC%2BD28Xks1els78%3D
33. 3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement? J Neurochem 103 997 1008 10.1111/j.1471-4159.2007.04789.x 1:CAS:528:DC%2BD2sXhtlSitLbN 17680985
34. 2-adrenoceptors in the isolated human right atrium Naunyn-Schmiedeberg's Arch Pharmacol 335 561 566 10.1007/BF00169125 1:CAS:528:DyaL2sXkslSmsrc%3D
35. S Krief F Lönnqvist S Raimbault B Baude A van Spronsen P Arner AD Strosberg D Ricquier LJ Emorine 1993 Tissue distribution of beta 3-adrenergic receptor mRNA in man J Clin Invest 91 344 349 10.1172/JCI116191 1:CAS:528:DyaK3sXpsV2hsw%3D%3D 8380813
36. K Kuratani H Kodama I Yamaguchi 1994 Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat J Pharmacol Exp Ther 270 559 565 1:CAS:528:DyaK2cXmsVGmsr8%3D 7915314
37. EJ Lezama AA Konkar MM Salazar-Bookaman DD Miller DR Feller 1996 Pharmacological study of atypical β-adrenoceptors in rat esophageal smooth muscle Eur J Pharmacol 308 69 80 10.1016/0014-2999(96)00236-1 1:CAS:528:DyaK28XktVOmsLY%3D 8836634
38. 3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn in press
39. DP McLaughlin A MacDonald 1991 Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical β-adrenoceptor Br J Pharmacol 103 1351 1356 1:CAS:528:DyaK3MXks1Ggsr0%3D 1679358
40. MC Michel S Parra 2008 Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle Naunyn-Schmiedeberg's Arch Pharmacol 378 217 224 10.1007/s00210-008-0316-5 1:CAS:528:DC%2BD1cXosVCrsb8%3D
41. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate Br J Pharmacol 147 S88 S119 10.1038/sj.bjp.0706619 1:CAS:528:DC%2BD28XhtFGqsLY%3D 16465187
42. MC Michel T Wieland G Tsujimoto 2009 How reliable are G-protein-coupled receptor antibodies? Naunyn-Schmiedeberg's Arch Pharmacol 377 385 388 10.1007/s00210-009-0395-y
43. 3-adrenoceptors in rat retinal blood vessels. Naunyn-Schmiedeberg's Arch Pharmacol in press
44. J Nedergaard B Cannon 2010 The changed metabolic world with human brown adipose tissue: therapeutic visions Cell Metabolism 11 268 272 10.1016/j.cmet.2010.03.007 1:CAS:528:DC%2BC3cXlsVajtbk%3D 20374959
45. J Nedergaard T Bengtsson B Cannon 2007 Unexpected evidence for active brown adipose tissue in adult humans Am J Physiol 293 E444 E452 1:CAS:528:DC%2BD2sXpt12rurk%3D
46. 2-Adrenoceptors and non-β-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice Br J Pharmacol 158 1676 1682 10.1111/j.1476-5381.2009.00472.x 1:CAS:528:DC%2BD1MXhs1Whtr7E 19912225
47. 3-adrenoceptor-mediated relaxation of rat oesophagus smooth muscle by protein kinase C Eur J Pharmacol 495 75 81 10.1016/j.ejphar.2004.05.008 1:CAS:528:DC%2BD2cXltF2qsbk%3D 15219823
48. MA Oriowo O Thulesius 1999 Functional characterization of β-adrenoceptors mediating relaxation in sheep gallbladder Fundam Clin Pharmacol 13 187 192 10.1111/j.1472-8206.1999.tb00337.x 1:CAS:528: DyaK1MXitlGlsrg%3D 10226762
49. A Otsuka H Shinbo R Matsumoto Y Kurita S Ozono 2008 Expression and functional role of β-adrenoceptors in the human urinary bladder Naunyn-Schmiedeberg's Arch Pharmacol 377 473 481 10.1007/s00210-008-0274-y 1:CAS:528:DC%2BD1cXnsVSqtbw%3D
50. 3-adrenoceptor and its functional role in the human ureter J Urol 164 1364 1370 10.1016/S0022-5347(05) 67200-X 1:CAS:528:DC%2BD3cXntVCjur0%3D 10992416
51. 3-adrenoceptors in human atrial myocardium Br J Pharmacol 138 521 529 10.1038/sj.bjp.0705065 1:CAS:528:DC%2BD3sXhvFSru7w%3D 12569077
52. W Pradidarcheep J Stallen WT Labruyere NF Dabhoiwala MC Michel WH Lamers 2009 Lack of specificity of commercially available antisera against muscarinic and adrenergic receptors Naunyn-Schmiedeberg's Arch Pharmacol 379 397 402 10.1007/s00210-009-0393-0 1:CAS:528:DC%2BD1MXitFKisLk%3D
53. 125I]-cyanopindolol binding sites in rat soleus muscle Br J Pharmacol 109 344 352 1:CAS:528:DyaK3sXkvVKksLk%3D 8102926
54. 3-adrenoceptors in human colon Br J Pharmacol 120 1527 1535 10.1038/sj.bjp.0701056 1:CAS:528:DyaK2sXjtVGrs7k%3D 9113375
55. 3- adrenoceptors in rat ileum Br J Pharmacol 127 949 961 10.1038/sj.bjp.0702605 1:CAS:528:DyaK1MXktlOms7w%3D 10433503
56. 2- adrenoceptor is resistant to desensitisation after sustained agonist stimulation Br J Pharmacol 141 831 841 10.1038/sj.bjp.0705616 1:CAS:528: DC%2BD2cXivFCgsb0%3D 14769781
57. 3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies Pharmacol Ther 111 652 673 10.1016/j.pharmthera.2005.12.002 1:CAS:528:DC%2BD28Xns1Sks7w%3D 16480771
58. 3-adrenoceptor produced by SR59230A relative to receptor agonists Mol Pharmacol 74 1359 1368 10.1124/mol.107.035337
59. 3-adrenoceptor Mol Pharmacol 74 1417 1428 10.1124/mol.108. 046979 1:CAS:528:DC%2BD1cXhtlCnt77K 18684840
60. 2+ current J Clin Invest 118 3219 3227 1:CAS:528: DC%2BD1cXhtV2isbjI 18704193
61. 3-Adrenergic receptors regulate retinal endothelial cell migration and proliferation J Biol Chem 278 20681 20686 10.1074/jbc.M300368200 1:CAS:528:DC%2BD3sXkt1Wisr8%3D 12670949
62. 3-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders Neuropsychopharmacol 33 574 587 10.1038/sj.npp.1301424 1:CAS:528:DC%2BD1cXmsFSksg%3D%3D
63. 3-adrenoceptor mRNA in rat brain Br J Pharmacol 116 2547 2548 1:CAS:528:DyaK2MXps1agsr0%3D 8590968
64. 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human Mol Pharmacol 43 343 348 1:CAS:528:DyaK3sXitVGrs78%3D 8383799
65. Y Tomiyama M Murakami Y Yamazaki M Kojima M Akahane 2003 Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter Pharmacology 68 140 146 10.1159/000070171 1:CAS:528:DC%2BD3sXkt1KmsL8%3D 12784085
66. JD Urban WP Clarke M von Zastrow DE Nichols B Kobilka H Weinstein JA Javitch BL Roth A Christopoulos PM Sexton KJ Miller M Spedding RB Mailman 2007 Functional selectivity and classical concepts of quantitative pharmacology J Pharmacol Exp Ther 320 1 13 10.1124/jpet.106.104463 1:CAS:528: DC%2BD2sXjsFersw%3D%3D 16803859
67. 3- adrenoceptor agonist SR58611A ameliorates experimental colitis in rats Neurogastroenterol Motil 20 1030 1041 10.1111/j.1365-2982.2008.01138.x 1:CAS:528:DC%2BD1cXhtFKisLbO 18492028
68. 3-adrenoceptors Naunyn-Schmiedeberg's Arch Pharmacol 374 385 398 10.1007/s00210-006-0127-5 1:CAS:528:DC%2BD2sXhsVersrs%3D
69. 3-adrenoceptors expressed in CHO or HEK293 cells Naunyn-Schmiedeberg's Arch Pharmacol 379 213
70. I Wanajo Y Tomiyama Y Yamazaki M Kojima N Shibata 2004 Pharmacological characterization of β-adrenoceptor subtypes mediating relaxation in porcine isolated uretreral smooth muscle J Urol 172 1155 1159 10.1097/01.ju.0000133557. 39515.b6 1:CAS:528:DC%2BD2cXms1GrsL8%3D 15311061
71. T Yamanishi CR Chapple K Yasuda K Yoshida R Chess-Williams 2003 The functional role of β-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle J Urol 170 2508 2511 10.1097/01.ju.0000085596.11247.78 14634461